Cancer screening study for HIV-infected patients by blood transfusio

Not Applicable

Recruiting

• Conditions: HIV infection; HIV-1, cancer; D046650

• Registration Number: JPRN-jRCT1032220397
• Lead Sponsor: Watanabe Koji

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-10-20
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

1.HIV infected person caused by transfusions of HIV-tainted blood products
2.A written informed consent was obtained

Exclusion Criteria

1.Severe underlying and/or active AIDS disease that need to be treated
2.Patients who have difficulty to participate in this study due to psychological disease
3.Patients who are judged to be inappropriate in participation by the attending docter

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To demonstrate incidence(per 100 person-year) of the NADM among HIV infected patients by blood <br>transfusion

Secondary Outcome Measures

Name	Time	Method
Identification of the risk factors for NADM among HIV infected patients by blood transfusion